Prevalence of dietary supplement use in patients with proven or suspected cardiovascular disease

Related Experiment Videos

Yu Sun Bin1, Hosen Kiat

  • 1Cardiac Health Institute, 173 Shaftsbury Road, Eastwood, NSW 2122, Australia.

Insights

Dietary supplement use is common in cardiac patients, with many unaware of potential interactions with prescription medications. Healthcare providers should proactively inquire about supplement use to ensure patient safety and optimize cardiovascular care.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Cardiovascular disease is a leading cause of mortality globally.
  • Dietary supplement use is prevalent across various populations.
  • The interaction between dietary supplements and cardiovascular medications is not fully understood.

Purpose of the Study:

  • To systematically review and describe the prevalence of dietary supplement use among patients with cardiovascular risk factors or established cardiovascular disease.
  • To identify the types of supplements commonly used and the reasons for their use.
  • To assess the extent of concurrent use of supplements with prescription medications and physician awareness.

Main Methods:

  • A systematic search of multiple bibliographic databases (Medline, EMBASE, CINAHL, AMED, Meditext, H&S, IPA) was performed.
  • Studies investigating supplement use in individuals with cardiovascular risk factors or disease were included.
  • Twenty studies meeting the review criteria were analyzed.

Main Results:

  • Dietary supplements were used by a median of 36% of cardiac patients.
  • Vitamin/mineral supplements were used by 36%, and herbal supplements by 12%.
  • A significant proportion of patients (16-64%) used supplements with prescription drugs, often without physician awareness (39-95%).

Conclusions:

  • Dietary supplement consumption is common in patients with cardiovascular disease.
  • Concurrent use of supplements with prescription medications is frequent, highlighting potential safety concerns.
  • Physicians should be more proactive in inquiring about supplement use to improve patient management and safety.

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...